AstraZeneca, Daiichi Sankyo partner with Summit to test cancer drug combo

AstraZeneca, Daiichi Sankyo, and Summit Therapeutics will jointly test cancer drugs Datroway and ivonescimab in a Phase III trial for triple-negative breast cancer

Показати на планеті →

Оригінал у джерелі →